Cornerstone Robotics Closes Oversubscribed Round of Approximately US$200 mn
Cornerstone Robotics (the “Company”), a number one international innovator in surgical robotics, is happy to announce the closing of an oversubscribed new financing spherical of roughly US$200 million. This financing spherical attracts funding from a worldwide strategic investor, some international institutional or sovereign wealth funds, and current shareholders. The proceeds from this spherical will primarily be used to speed up commercialisation and drive continued technological innovation by Cornerstone Robotics.
Top-tier Global Investors Join to Accelerate Global Expansion
With its industry-leading applied sciences and powerful development potential within the subject of surgical robotics, Cornerstone Robotics has attracted a worldwide strategic investor on this financing spherical. The Company additionally welcomed some international institutional or sovereign wealth funds, whose participation will additional help Cornerstone Robotics’ market entry and strategic partnerships globally. Existing shareholders have additionally elevated their funding, reaffirming their robust confidence within the Company’s technological capabilities and future roadmap, commercialization progress, and long-term development potential. Together, this highly effective investor lineup strengthens Cornerstone Robotics’ international basis and accelerates its mission to make protected, environment friendly, and accessible surgical robotic applied sciences accessible to healthcare suppliers worldwide.
Advancing Global Surgical Robotics
Since its institution in 2019, Cornerstone Robotics has adhered to its imaginative and prescient of “main medical innovation for a more healthy world”. Through full-stack in-house R&D and deep vertical integration, the Company has turn out to be a number one international innovator in surgical robotics and associated applied sciences.
The Company’s flagship product, the Sentire® Endoscopic Surgical System, has obtained approval from China’s National Medical Products Administration (NMPA) and has entered scientific use in main hospitals throughout the Chinese mainland, Hong Kong, and Europe. By collaborating with high worldwide medical and educational establishments, Cornerstone Robotics is deepening its dedication to advancing scientific coaching, expertise adoption, and scholarly alternate, empowering international medical accessibility to succeed in a brand new age.
Professor Samuel Au, Founder and CEO of Cornerstone Robotics, stated: “The yr 2025 marks an necessary milestone within the improvement journey of Cornerstone Robotics. We prolong our heartfelt gratitude to our new and current shareholders for his or her belief and help. This represents not solely recognition of the profitable scientific utility of our improvements, but additionally robust confidence in Cornerstone Robotics’ long-term development. Moving ahead, we are going to stay dedicated to innovation-driven improvement and deepen our international presence, bringing protected, high-quality, and accessible surgical robotic options to sufferers and healthcare suppliers all over the world.”
UBS Group served because the Company’s monetary advisor on this transaction, Global Law Office served because the Company’s transaction authorized counsel, and JunHe served because the Company’s mental property authorized counsel.
The publish Cornerstone Robotics Closes Oversubscribed Round of Approximately US$200 mn first appeared on AI-Tech Park.